In consideration of fatty liver groups, the results showed that the combination therapy group (NAFLD+LGG+ HIIT) caused a significant decrease in TIMP-1 mRNA compared to the NAFLD group (p < 0.001) (Figure 3(Fig. 3)). This evidence concerns the gene TIMP1 and fatty liver disease.